Biomarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. is a global biotechnology company based in Novato, California, dedicated to developing transformative medicines for life-threatening genetic conditions. Since its founding in 1997, the company has successfully marketed eight products and continues to advance its robust pipeline of investigational therapies across various stages of clinical and preclinical development.
With a focus on patients and collaboration, BioMarin applies its scientific expertise to address serious health challenges, including achondroplasia and severe hemophilia A. The company's commitment to pushing the boundaries of science is reflected in its holistic approach to understanding genetic disorders and improving patient care.
Generated from the website